Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/13/18 → 8/31/50 |
Funding
- Ovid Therapeutics Inc.
TAK-935-2002: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TAK-935 AS AN ADJUNCTIVE THERAPY IN PEDIATRIC PATIENTS WITH DEVELOPMENTAL AND/OR EPI
- Laux, Linda C (PD/PI)
- Millichap, John J (PD/PI)
Project: Research project